Cargando…
855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
BACKGROUND: Many antimicrobial stewardship programs have set goals to reduce the use of fluoroquinolones because of risks of causing C. difficile and other adverse safety events. The US Food and Drug Administration issued a black box label warning for fluoroquinolones in June 2016 recommending avoid...
Autores principales: | Yarrington, Michael, Anderson, Deverick J, Ashley, Elizabeth Dodds, Jones, Travis, Johnson, Melissa, Lokhnygina, Yuliya, Sexton, Daniel, Moehring, Rebekah W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252437/ http://dx.doi.org/10.1093/ofid/ofy209.040 |
Ejemplares similares
-
1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016
por: Willis, Zachary, et al.
Publicado: (2018) -
Harvesting the Low Hanging Fruit: A Benchmarking Tool for Implementation of Intravenous to Oral Antibiotic Switch Programs in 14 Southeastern Community Hospitals
por: Garner, Bronwen, et al.
Publicado: (2015) -
Blood Culture Utilization at Six Southeastern US Hospitals
por: Warren, Bobby, et al.
Publicado: (2021) -
1823. Signal or Noise? A Comparison of Methods to Identify Outliers in Antimicrobial Use (AU)
por: Moehring, Rebekah W, et al.
Publicado: (2018) -
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
por: Hagan, John B., et al.
Publicado: (2021)